位置:首页 > 蛋白库 > CC186_HUMAN
CC186_HUMAN
ID   CC186_HUMAN             Reviewed;         898 AA.
AC   Q7Z3E2; Q2M2V6; Q3ZB81; Q6NS91; Q7RTP1; Q8N117; Q8N3G3; Q8N6C2; Q9NWA3;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2005, sequence version 2.
DT   03-AUG-2022, entry version 135.
DE   RecName: Full=Coiled-coil domain-containing protein 186;
DE   AltName: Full=CTCL tumor antigen HD-CL-01/L14-2;
GN   Name=CCDC186; Synonyms=C10orf118;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LYS-271.
RC   TISSUE=Endometrial tumor, and Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ILE-85 AND LYS-271.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 74-791, AND VARIANTS ILE-85; GLN-179 AND
RP   LYS-271.
RC   TISSUE=Lymphoma;
RX   PubMed=14996095; DOI=10.1111/j.1365-2133.2004.05651.x;
RA   Hartmann T.B., Thiel D., Dummer R., Schadendorf D., Eichmueller S.;
RT   "SEREX identification of new tumour-associated antigens in cutaneous T-cell
RT   lymphoma.";
RL   Br. J. Dermatol. 150:252-258(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 614-898.
RC   TISSUE=Embryo, and Prostate;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   IDENTIFICATION.
RX   PubMed=12783626; DOI=10.1186/1471-2164-4-22;
RA   Oduru S., Campbell J.L., Karri S., Hendry W.J., Khan S.A., Williams S.C.;
RT   "Gene discovery in the hamster: a comparative genomics approach for gene
RT   annotation by sequencing of hamster testis cDNAs.";
RL   BMC Genomics 4:22-22(2003).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH70368.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence starting in position 212.; Evidence={ECO:0000305};
CC       Sequence=AAM44457.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAM44457.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence starting in position 792.; Evidence={ECO:0000305};
CC       Sequence=BAA91480.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC03926.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL834368; CAD39031.2; -; mRNA.
DR   EMBL; BX537964; CAD97928.1; -; mRNA.
DR   EMBL; BC070368; AAH70368.1; ALT_SEQ; mRNA.
DR   EMBL; BC103499; AAI03500.1; -; mRNA.
DR   EMBL; BC105632; AAI05633.1; -; mRNA.
DR   EMBL; BC152306; AAI52307.1; -; mRNA.
DR   EMBL; AF273054; AAM44457.1; ALT_SEQ; mRNA.
DR   EMBL; AK001050; BAA91480.1; ALT_INIT; mRNA.
DR   EMBL; AK092620; BAC03926.1; ALT_SEQ; mRNA.
DR   EMBL; BK001329; DAA01463.1; -; mRNA.
DR   CCDS; CCDS7587.1; -.
DR   RefSeq; NP_001308758.1; NM_001321829.1.
DR   RefSeq; NP_060487.2; NM_018017.3.
DR   RefSeq; NP_694981.1; NM_153249.1.
DR   AlphaFoldDB; Q7Z3E2; -.
DR   SMR; Q7Z3E2; -.
DR   BioGRID; 120401; 28.
DR   DIP; DIP-47298N; -.
DR   IntAct; Q7Z3E2; 18.
DR   MINT; Q7Z3E2; -.
DR   STRING; 9606.ENSP00000358293; -.
DR   GlyGen; Q7Z3E2; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q7Z3E2; -.
DR   PhosphoSitePlus; Q7Z3E2; -.
DR   BioMuta; CCDC186; -.
DR   DMDM; 71152997; -.
DR   EPD; Q7Z3E2; -.
DR   jPOST; Q7Z3E2; -.
DR   MassIVE; Q7Z3E2; -.
DR   MaxQB; Q7Z3E2; -.
DR   PaxDb; Q7Z3E2; -.
DR   PeptideAtlas; Q7Z3E2; -.
DR   PRIDE; Q7Z3E2; -.
DR   ProteomicsDB; 69040; -.
DR   Antibodypedia; 2907; 29 antibodies from 10 providers.
DR   DNASU; 55088; -.
DR   Ensembl; ENST00000369287.8; ENSP00000358293.3; ENSG00000165813.20.
DR   Ensembl; ENST00000648613.1; ENSP00000498136.1; ENSG00000165813.20.
DR   GeneID; 55088; -.
DR   KEGG; hsa:55088; -.
DR   MANE-Select; ENST00000369287.8; ENSP00000358293.3; NM_018017.4; NP_060487.2.
DR   UCSC; uc001lbb.2; human.
DR   CTD; 55088; -.
DR   DisGeNET; 55088; -.
DR   GeneCards; CCDC186; -.
DR   HGNC; HGNC:24349; CCDC186.
DR   HPA; ENSG00000165813; Low tissue specificity.
DR   MIM; 619249; gene.
DR   neXtProt; NX_Q7Z3E2; -.
DR   OpenTargets; ENSG00000165813; -.
DR   PharmGKB; PA134904295; -.
DR   VEuPathDB; HostDB:ENSG00000165813; -.
DR   eggNOG; KOG0992; Eukaryota.
DR   eggNOG; KOG1836; Eukaryota.
DR   GeneTree; ENSGT00720000108851; -.
DR   HOGENOM; CLU_007958_0_0_1; -.
DR   InParanoid; Q7Z3E2; -.
DR   OMA; QEHTIKR; -.
DR   OrthoDB; 604365at2759; -.
DR   PhylomeDB; Q7Z3E2; -.
DR   TreeFam; TF328785; -.
DR   PathwayCommons; Q7Z3E2; -.
DR   SignaLink; Q7Z3E2; -.
DR   BioGRID-ORCS; 55088; 10 hits in 1063 CRISPR screens.
DR   ChiTaRS; CCDC186; human.
DR   GeneWiki; C10orf118; -.
DR   GenomeRNAi; 55088; -.
DR   Pharos; Q7Z3E2; Tdark.
DR   PRO; PR:Q7Z3E2; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q7Z3E2; protein.
DR   Bgee; ENSG00000165813; Expressed in sperm and 178 other tissues.
DR   ExpressionAtlas; Q7Z3E2; baseline and differential.
DR   Genevisible; Q7Z3E2; HS.
DR   GO; GO:0005802; C:trans-Golgi network; IBA:GO_Central.
DR   GO; GO:0031267; F:small GTPase binding; IBA:GO_Central.
DR   GO; GO:0035773; P:insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0009617; P:response to bacterium; IEA:Ensembl.
DR   GO; GO:0099518; P:vesicle cytoskeletal trafficking; IBA:GO_Central.
DR   InterPro; IPR038830; CCDC186.
DR   PANTHER; PTHR18911; PTHR18911; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Coiled coil; Phosphoprotein; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   CHAIN           2..898
FT                   /note="Coiled-coil domain-containing protein 186"
FT                   /id="PRO_0000089823"
FT   REGION          1..43
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          68..95
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          702..749
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          201..712
FT                   /evidence="ECO:0000255"
FT   COILED          759..803
FT                   /evidence="ECO:0000255"
FT   COILED          855..894
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1..16
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        26..43
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        712..749
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   MOD_RES         740
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8C9S4"
FT   VARIANT         85
FT                   /note="T -> I (in dbSNP:rs1061159)"
FT                   /evidence="ECO:0000269|PubMed:14996095,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_023047"
FT   VARIANT         179
FT                   /note="R -> Q (in dbSNP:rs12782946)"
FT                   /evidence="ECO:0000269|PubMed:14996095"
FT                   /id="VAR_023048"
FT   VARIANT         271
FT                   /note="Q -> K (in dbSNP:rs7095762)"
FT                   /evidence="ECO:0000269|PubMed:14996095,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005"
FT                   /id="VAR_023049"
FT   CONFLICT        74..76
FT                   /note="GGG -> IRH (in Ref. 3; AAM44457)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        209
FT                   /note="I -> T (in Ref. 2; AAH70368)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        614
FT                   /note="D -> I (in Ref. 4; BAA91480)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        745
FT                   /note="G -> E (in Ref. 1; CAD39031)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        857
FT                   /note="Q -> L (in Ref. 1; CAD97928)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   898 AA;  103687 MW;  47E8A9BD547C82D3 CRC64;
     MSETDHIAST SSDKNVGKTP ELKEDSCNLF SGNESSKLEN ESKLLSLNTD KTLCQPNEHN
     NRIEAQENYI PDHGGGEDSC AKTDTGSENS EQIANFPSGN FAKHISKTNE TEQKVTQILV
     ELRSSTFPES ANEKTYSESP YDTDCTKKFI SKIKSVSASE DLLEEIESEL LSTEFAEHRV
     PNGMNKGEHA LVLFEKCVQD KYLQQEHIIK KLIKENKKHQ ELFVDICSEK DNLREELKKR
     TETEKQHMNT IKQLESRIEE LNKEVKASRD QLIAQDVTAK NAVQQLHKEM AQRMEQANKK
     CEEARQEKEA MVMKYVRGEK ESLDLRKEKE TLEKKLRDAN KELEKNTNKI KQLSQEKGRL
     HQLYETKEGE TTRLIREIDK LKEDINSHVI KVKWAQNKLK AEMDSHKETK DKLKETTTKL
     TQAKEEADQI RKNCQDMIKT YQESEEIKSN ELDAKLRVTK GELEKQMQEK SDQLEMHHAK
     IKELEDLKRT FKEGMDELRT LRTKVKCLED ERLRTEDELS KYKEIINRQK AEIQNLLDKV
     KTADQLQEQL QRGKQEIENL KEEVESLNSL INDLQKDIEG SRKRESELLL FTERLTSKNA
     QLQSESNSLQ SQFDKVSCSE SQLQSQCEQM KQTNINLESR LLKEEELRKE EVQTLQAELA
     CRQTEVKALS TQVEELKDEL VTQRRKHASS IKDLTKQLQQ ARRKLDQVES GSYDKEVSSM
     GSRSSSSGSL NARSSAEDRS PENTGSSVAV DNFPQVDKAM LIERIVRLQK AHARKNEKIE
     FMEDHIKQLV EEIRKKTKII QSYILREESG TLSSEASDFN KVHLSRRGGI MASLYTSHPA
     DNGLTLELSL EINRKLQAVL EDTLLKNITL KENLQTLGTE IERLIKHQHE LEQRTKKT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024